Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017 Year: 2017
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007
Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014
Malignant pericardial effusion in lung cancer patients Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions Year: 2006
Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Epidemiology and clinical problems of orphant pleural adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial Source: Eur Respir J 2010; 36: 1362-1369 Year: 2010
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006
Pre-operative chemotherapy in patients with resectable non-small cell lung cancer (NSCLC): the MRC LU22/NVALT/EORTC 08012 multi-centre randomised trial Source: Eur Respir J 2007; 30: Suppl. 51, 240s Year: 2007
Early symptoms in suspected lung cancer: a prospective cohort study Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001
Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020
Pulmonary rehabilitation after radically treated lung cancer patients: a pilot study Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008
The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003